Harler Mary Beth
- SEC CIK
- 0002018699
No open-market purchases or sales filed in the past year.
Current role at each company
- IGMS IGM Biosciences, Inc.Chief Executive Officeras of Aug 14, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Harler Mary Beth as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 25, 2025 (view filing) | Jul 23 | 2 days | Harler Mary BethChief Executive Officer | SSale | −14.5K | $1.27 | −$18.4K | −4.3%323.7K after | |
| Jun 20, 2025 (view filing) | Jun 16 | 4 daysLate | Harler Mary BethChief Executive Officer | SSale | −1.52K | $1.20 | −$1.83K | −0.4%338.2K after | |
| Mar 18, 2025 (view filing) | Mar 14 | 4 days | Harler Mary BethChief Executive Officer | SSale | −7.33K | $1.23 | −$9.01K | −2.1%339.7K after | |
| Dec 18, 2024 (view filing) | Dec 16 | 2 days | Harler Mary BethChief Executive Officer | SSale | −1.71K | $7.48 | −$12.8K | −0.5%347.0K after | |
| Sep 17, 2024 (view filing) | Sep 13 | 4 days | Harler Mary BethHead, Research & Autoimmunity | SSale | −1.49K | $11.54 | −$17.2K | −0.9%163.7K after | |
| Jun 18, 2024 (view filing) | Jun 14 | 4 days | Harler Mary BethHead, Research & Autoimmunity | SSale | −1.57K | $7.58 | −$11.9K | −1.8%85.2K after |